Aventure Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 11-07-2024
- Paid Up Capital ₹ 0.20 M
as on 11-07-2024
- Company Age 16 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 M
as on 11-07-2024
- Revenue %
(FY 2022)
- Net Worth -1.01%
(FY 2022)
- Total Assets 3.05%
(FY 2022)
About Aventure Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.20 M.
The company currently has active open charges totaling ₹1.00 M.
Pankaj Mehra, Ranju Bansal, Sanjay Bansal, and Two other members serve as directors at the Company.
- CIN/LLPIN
U51397DL2008PTC184593
- Company No.
184593
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Nov 2008
- Date of AGM
20 Jul 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
South Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Aventure Pharma?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pankaj Mehra  | Director | 20-Nov-2009 | Current |
| Ranju Bansal | Director | 28-Jun-2011 | Current |
| Sanjay Bansal | Director | 03-Nov-2008 | Current |
| Rajni Bansal | Director | 06-Apr-2021 | Current |
| Arun Bansal | Director | 03-Nov-2008 | Current |
Financial Performance and Corporate Structure Insights of Aventure Pharma.
Aventure Pharma Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth dipped by a decrease of 1.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Aventure Pharma?
In 2021, Aventure Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ssb Central Hospital & Research Centre LimitedActive 16 years 11 monthsArun Bansal is a mutual person
Rrs Pharma & Surgical Twin Private LimitedActive 13 years 9 monthsRanju Bansal, Sanjay Bansal and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 11 Sep 2023 | ₹1.00 M | Open |
How Many Employees Work at Aventure Pharma?
Unlock and access historical data on people associated with Aventure Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aventure Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aventure Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
